Skip to content Skip to footer

Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition

Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Share this story

Definitions of key acronyms and terms used throughout The Psychedelics as Medicine Report.

A

ACT
acceptance and commitment therapy
ADHD
attention deficit hyperactivity disorder
AUD
alcohol use disorder

B

BTD
Breakthrough Therapy designation

C

CBCT
Cognitive behavioural cognitive therapy
CBT
Cognitive behavioural therapy
CIIS
California Institute of Integral Studies
CSE
Canadian Stock Exchange
CNS
central nervous system

D

DALYs
disability adjusted life years
DEA
Drug Enforcement Administration
DMT
Dimethyltryptamine
DSCP
Drug software combination products

E

ECT
electroconvulsive therapy
EDs
eating disorders
EEG
electroencephalogram
EMA
European Medicine Agency

F

FDA
Food and Drug Administration
fMRI
functional magnetic resonance imaging

G

GITA
Global ibogaine therapy alliance
GMP
Good Manufacturing Practice

I

ICL
Imperial College London
IND
investigational new drug
IM
intramuscular
IP
intellectual property
IPO
initial public offering
IV
intravenous

L

LSD
lysergic acid diethylamide

M

MAOIs
monoamine oxidase inhibitors
MAPS
Multidisciplinary Association for Psychedelic Studies
MAPS PBC
Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation
MDD
major depressive disorder
MDMA
methylenedioxymethamphetamine
MMA
Mind Medicine Australia

N

NGO
non-government organisation
NHS
National Health Service

O

OCD
obsessive-compulsive disorder
OUD
opioid use disorder

P

PAT
psychedelic assisted therapy
PPD
postpartum depression
PTSD
post-traumatic stress disorder

R

RCT
randomised controlled trial

S

SI
suicidal ideation
SNRIs
serotonin and norepinephrine reuptake inhibitors
SSRIs
selective serotonin reuptake inhibitors
SUD
substance use disorder

T

TBI
traumatic brain injury
TGA
Therapeutic Goods Administration
TRD
treatment-resistant depression

U

UCLA
University of California, Los Angeles

V

VR
virtual reality

W

WHO
World Health Organisation
Prefer the full dataset? Download the complete report (PDF).
Recent posts
March 26, 2026
Five Takeaways from the Global Medical Cannabis Market Review 2026
March 9, 2026
Cannabis Telemedicine: What Poland’s Market Crash and Recovery Tells Us About Regulatory Risk
March 4, 2026
Cannabis Market Research: A Buyer’s Guide to Reports, Data, and Market Intelligence
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition

Catch up on our newest articles that you might have missed

lou-batier-5EoWFa_Htdo-unsplash
March 26, 2026
Five Takeaways from the Global Medical Cannabis Market Review 2026
The global medical cannabis market has shifted more in the past 12 months than in the previous five years combined....
kamil-gliwinski-xcPw1-5OHTk-unsplash
March 9, 2026
Cannabis Telemedicine: What Poland’s Market Crash and Recovery Tells Us About Regulatory Risk
Cannabis telemedicine has become the dominant access channel in the world’s largest medical cannabis markets, but also their Achilles heel. ...
inaki-del-olmo-NIJuEQw0RKg-unsplash
March 4, 2026
Cannabis Market Research: A Buyer’s Guide to Reports, Data, and Market Intelligence
The cannabis industry generates more market research than almost any sector of its size. A search for cannabis market data...
louis-reed-pwcKF7L4-no-unsplash (1)
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact